NICE Recommends Dupixent (dupilumab) for the Treatment of Severe Asthma
FirstWord Pharma,
Mon, October 18, 2021, 3:39 AM·7 min read Final Appraisal Determination (FAD) means a novel biologic will be routinely…
Mon, October 18, 2021, 3:39 AM·7 min read Final Appraisal Determination (FAD) means a novel biologic will be routinely…
READING, England, Oct. 18, 2021 /PRNewswire/ -- The National Institute for Health and Care Excellence (NICE) has issued a Final…